Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Outcomes of Pharmacist-Led Treatment of Hepatitis C in the Virginia Department of Corrections.

Journal of correctional health care : the official journal of the National Commission on Correctional Health Care - 1 Dec 2023

Masuda Quamrun N, Smith Jamie E, Gaines JaViere, Dillingham Rebecca A

Abstract excerpt

A higher proportion of people in correctional settings have, or are at risk for, hepatitis C virus (HCV) due to socioeconomic factors, mental health concerns, substance use disorders, history of high-risk experiences, and more. Compared with the general population, the prevalence of HCV is 10 times higher among people who are incarcerated. The objective of this retrospective cohort study was to describe the HCV...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepacivirus

Share to Hepatitis C

Share to Hepatitis C, Chronic

Share to Treatment Outcome

Share to Virginia

Source

Identifiers

PMID: 37943532
DOI: 10.1089/jchc.23.03.0025

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Outcomes of Pharmacist-Led Treatment of Hepatitis C in the Virginia Department of Corrections.PMID 37943532Read ↗

Treatment of HCV in the Department of Corrections in the Era of Oral Medications.Semantic proximity Read ↗

Ongoing Gaps in the Hepatitis C Care Cascade during the Direct-Acting Antiviral Era in a Large Retrospective Cohort in Canada: A Population-Based StudySemantic proximity Read ↗

An evaluation of the hepatitis C testing, care and treatment program in the country of Georgia's corrections system, December 2013 - April 2015.Semantic proximity Read ↗

Treatment effectiveness and side effects of patients with hepatitis C in the prisons of Southern Taiwan: a real-life retrospective analysis.Semantic proximity Read ↗

Direct-Acting Antiviral Therapy Outcomes in Canadian Chronic Hepatitis C Telemedicine Patients.Semantic proximity Read ↗

Effect of sustained viral clearance on liver-related mortality among individuals living with hepatitis C by treatment era: a population-based retrospective cohort studySemantic proximity Read ↗

Real-world use of elbasvir-grazoprevir in patients with chronic hepatitis C: retrospective analyses from the TRIO network.Semantic proximity Read ↗

Cascade of Care for Hepatitis C Virus Infection Within the US Veterans Health Administration.Semantic proximity Read ↗

Harm reduction-based and peer-supported hepatitis C treatment for people who inject drugs in Georgia.Semantic proximity Read ↗

Feasibility and outcome of HCV treatment in a Canadian federal prison population.Semantic proximity Read ↗

Characterizing the Burden of Hepatitis C Infection Among Entrants to Pennsylvania State Prisons, 2004 to 2012.Semantic proximity Read ↗

What is the impact of a country-wide scale-up in antiviral therapy on the characteristics and sustained viral response rates of patients treated for hepatitis C?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.